Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB)
Status:
Completed
Trial end date:
2011-01-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to document the efficacy and safety profiles of single
intravenous dose of 5 mg zoledronic acid for the Chinese patients of Paget's Disease of Bone
(PDB).